Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 82.98 M84.74 M81.53 M84.02 M81.34 M 331.63 M Research & development 50.17 M45.42 M47.27 M46.21 M44.87 M 183.77 M Operating income 31.92 M37.01 M66.16 M22.44 M-29.64 M 95.96 M Non-Operating Income, Total 14.97 M5.2 M10.86 M16.26 M15.78 M 48.1 M Interest expense, net of interest capitalized 2.05 M815 K830 K829 K633 K 3.11 M Non-Operating Income, excl. Interest Expenses 14.98 M14.1 M14.6 M14.52 M11.99 M 55.21 M Unusual income/expense -14 K-8.9 M-3.74 M1.74 M3.79 M -7.11 M Pretax income 46.89 M42.2 M77.02 M38.7 M-13.86 M 144.06 M Equity in earnings ————— — Taxes 17.16 M5.15 M10.38 M-16 K-6.45 M 9.06 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 29.73 M37.05 M66.64 M38.71 M-7.41 M 135 M Discontinued operations ————— — Net income 29.73 M37.05 M66.64 M38.71 M-7.41 M 135 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 29.73 M37.05 M66.64 M38.71 M-7.41 M 135 M Basic earnings per share (Basic EPS) 0.230.280.510.29-0.06 1.02 Diluted earnings per share (Diluted EPS) 0.220.280.50.29-0.06 1.01 Average basic shares outstanding 131.87 M131.03 M130.8 M131.16 M131.34 M — Diluted shares outstanding 136.21 M135.22 M133 M134.89 M131.34 M — EBITDA 51.84 M57.09 M86.38 M42.87 M-8.83 M 177.51 M EBIT 31.92 M37.01 M66.16 M22.44 M-29.64 M 95.96 M Cost of revenue 187.84 M192.66 M214.19 M191.29 M182.51 M 780.64 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 19.91 M20.09 M20.22 M20.43 M20.82 M 81.55 M